40LOW

EIQ

ECHOIQLTD FPO [EIQ]
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia.
Healthcare · ASX Small Cap
$0.8600 +7.5%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical74
Catalyst53
Sentiment50
Fundamental55
Momentum75
Risk Gate42
Get alerts when EIQ's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track EIQ — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Pressing against the upper Bollinger Band — extended and may need to cool off
  • Trading above both moving averages — the trend is your friend here
  • Above-average volume (1.6x) on a green day — buyers stepping up
  • Just broke above 20-day resistance — a level that was capping price, now cleared
  • On a tear — up 34.4% over the last 5 days
  • Beating the Small Ords index — relative strength of 1.55, so it's outpacing the pack
  • Trading above the 200-day average — the long-term trend is on your side
  • Adequate cash runway (5 quarters)
  • Very high P/S ratio (5575.3x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week high (97% of range)
  • Capital raise activity (1 events)
  • CANSLIM N: Near 52-week high (breakout territory)
  • Sentiment is mixed — no strong consensus either way
  • Strong long-term momentum — up 153% over the past year (excluding last month)
  • Excellent risk-adjusted returns — Sharpe of 2.3 means strong gains without wild swings
  • The bigger volume days are the up days — volume-weighted momentum is positive (4.11%/day)
  • Altman Z-Score distress zone (1.77 < 1.81, low-confidence approx)
  • RBA hiking (-3pts)
  • Dilution risk: technical breakout with recent capital raise

Risk Signals

  • RSI is running hot — overbought territory, so expect some pullback risk
  • Stochastic is stretched into overbought — could need a breather
  • Revenue declining (-10%)
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -10% — the top line is shrinking
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about EIQ
"What's driving EIQ's score?" "How does EIQ compare to peers?" "Key risks for EIQ?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Agreement with Mayo Clinic for EchoSolv HF
NONE Cleansing Notice
NONE Application for quotation of securities - EIQ
Announcement tone +3pts

Recent ASX Announcements

2026-03-23 Agreement with Mayo Clinic for EchoSolv HF PRICE SENSITIVE
2026-03-17 Cleansing Notice
2026-03-17 Application for quotation of securities - EIQ
2026-03-13 Change of Director's Interest Notice x2
2026-03-13 Application for quotation of securities - EIQ

Key Metrics

$506.8M
Market Cap
3.1M
Avg Volume
1.6x
Vol Ratio
$0.17 — $0.79
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
-115.2%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / CatalystspassNear 52w High
SSupply & DemandneutralFloat: 72%
LLeader vs LaggardpassRS: 51
IInstitutional SponsorshipweakInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #87 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:EIQ vs ATXEIQ vs PNVEIQ vs IMM
Scout Pro — Deeper Analysis for EIQ
Try Pro free for 30 days
Share this analysis

Track EIQ and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required